Fingerprint
Dive into the research topics of 'Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: A single-group, multicentre, phase 2 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: A single-group, multicentre, phase 2 trial
Alice T. Shaw, Leena Gandhi, Shirish Gadgeel, Gregory J. Riely, Jeremy Cetnar, Howard West, D. R. Camidge, Mark A. Socinski, Alberto Chiappori, Tarek Mekhail, Bo H. Chao, Hossein Borghaei, Kathryn A. Gold, Ali Zeaiter, Walter Bordogna, Bogdana Balas, Oscar Puig, Volkmar Henschel, Sai Hong Ignatius Ou
Research output: Contribution to journal › Article › peer-review
576
Scopus
citations